A multistakeholder roundtable discussion, moderated by Maria Theodoulou, MD, of New York Oncology Hematology, focused on HER2-positive breast cancer diagnosis, treatment, and management. Dr. Theodoulou was joined by Andrew D. Seidman, MD, Melissa Carver, MSN, ARNP, AOCN, and Christine McGinn, MSN, APRN, ACNP-BC.
In this segment of the roundtable series, the panelists discuss how they talk to patients about a HER2-positive breast cancer diagnosis. They also speak about how to help patients understand the meaning of this diagnosis, and how to tailor treatment to an individual’s needs, preferences, and goals.